Gazette.govt.nzPursuant to section 20 of the Medicines Act 1981, the Minister of Health hereby consents to the distribution in New Zealand of the new medicines set out in the Schedule hereto:
Schedule
| Product: | Febuxostat |
| Active Ingredient: | Febuxostat 80mg |
| Dosage Form: | Film coated tablet |
| New Zealand Sponsor: | Teva Pharma (New Zealand) Limited |
| Manufacturer: | Watson Pharma Private Limited, Verna, India |
| Product: | Febuxostat |
| Active Ingredient: | Febuxostat 120mg |
| Dosage Form: | Film coated tablet |
| New Zealand Sponsor: | Teva Pharma (New Zealand) Limited |
| Manufacturer: | Watson Pharma Private Limited, Verna, India |
| Product: | Levonorgestrel BNM |
| Active Ingredient: | Levonorgestrel 1.5mg |
| Dosage Form: | Tablet |
| New Zealand Sponsor: | Boucher & Muir (New Zealand) Limited t/a BNM Group |
| Manufacturer: | Laboratorios Leon Farma S.A., Leon, Spain |
| Product: | Terlipressin Ever Pharma (1mg/5mL) |
| Active Ingredient: | Terlipressin acetate 0.2mg/mL equivalent to terlipressin 0.17mg/mL |
| Dosage Form: | Solution for injection |
| New Zealand Sponsor: | Pharmacy Retailing (NZ) Limited t/a Healthcare Logistics |
| Manufacturer: | EVER Pharma Jena GmbH, Jena, Germany |
| Product: | Terlipressin Ever Pharma (2mg/10mL) |
| Active Ingredient: | Terlipressin acetate 0.2mg/mL equivalent to terlipressin 0.17mg/mL |
| Dosage Form: | Solution for injection |
| New Zealand Sponsor: | Pharmacy Retailing (NZ) Limited t/a Healthcare Logistics |
| Manufacturer: | EVER Pharma Jena GmbH, Jena, Germany |
Dated this 24th day of April 2020.
CHRIS JAMES, Group Manager, Medsafe, Ministry of Health (pursuant to delegation given by the Minister of Health on 11 September 2013).